Hanmi Pharm. Co., Ltd. (KRX:128940)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Reconciliation of Inter-Sector Transactions	-92.77B	-113.14B	-114.82B	-101.69B	-89.72B
Overseas Medicine	402.40B	385.63B	397.69B	350.64B	288.73B
Overseas Medicine Growth	4.35%	-3.03%	13.42%	21.44%	41.86%
Medicine	1.15T	1.11T	1.10T	982.05B	917.02B
Medicine Growth	2.92%	1.57%	11.70%	7.09%	5.11%
Raw Drug Substance	91.28B	108.89B	111.07B	100.55B	87.16B
Raw Drug Substance Growth	-16.17%	-1.96%	10.46%	15.36%	-2.39%
Total	1.55T	1.50T	1.49T	1.33T	1.20T
Total Growth	3.48%	0.31%	11.97%	10.67%	11.84%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Republic of Korea	947.03B	918.60B	890.76B	826.08B	768.94B
Republic of Korea Growth	3.09%	3.13%	7.83%	7.43%	8.92%
China	405.75B	391.93B	404.85B	356.11B	321.56B
China Growth	3.53%	-3.19%	13.69%	10.75%	45.69%
The United States of America	82.24B	50.88B	67.99B	40.87B	27.43B
The United States of America Growth	61.63%	-25.16%	66.36%	49.00%	-39.09%
Japan	22.17B	56.13B	51.81B	44.80B	41.13B
Japan Growth	-60.50%	8.33%	15.65%	8.93%	-21.18%
Other	90.34B	77.96B	75.48B	63.69B	44.14B
Other Growth	15.89%	3.29%	18.51%	44.29%	-15.07%
Total	1.55T	1.50T	1.49T	1.33T	1.20T
Total Growth	3.48%	0.31%	11.97%	10.67%	11.84%

Source: S&P Global Market Intelligence.